Skip to main content
SpringerLink
Log in

Atrial natriuretic factor: Physiologic actions and implications in congestive heart failure

  • General Articles: Clinical Studies
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Summary

Atrial natriuretic factor (ANF) represents a newly recognized hormone of cardiac origin. This peptide is synthesized by the myocardial cells of both atria and released by atrial stretch. The hormone promotes sodium and water excretion by the kidney, inhibits the renin-angiotensin-aldosterone system, and reduces systemic arterial pressure. Specific receptors for ANF are present in the kidney, adrenal glands, vascular smooth muscle, platelets and central nervous system. Congrestive heart failure is characterized by increased circulating levels of ANF; however, there appears to be an attenuation in the renal response to the hormone.

Recent investigations have reported the effect of systemic administration of synthetic ANF to normal individuals and those with congestive heart failure. The hormone may promote a significant natriuresis and diuresis in addition to reducing arterial pressure and inhibiting renin and aldosterone secretion. Substantial questions remain as to the full physiologic significance and therapeutic potential of this hormone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ballermann BJ, Brenner BM. Role of atrial peptides in body fluid homeostasis.Circ Res 1986;58:619–630.

    Google Scholar 

  2. Cantin M, Genest J. The heart and atrial natriuretic factor. Endo Rev 1985;6:107–127.

    Google Scholar 

  3. Needleman P, Adams SP, Cole BR, et al. Atriopeptins as cardiac hormones.Hypertension 1985;7:46–482.

    Google Scholar 

  4. Laragh JH. Atrial natriuretic hormone, the reninaldosterone axis, and blood pressure—electrolyte homeostasis.New Engl J Med 1985;313:1330–1340.

    Google Scholar 

  5. Henry JP, Gauer OH, Reeves JL. Evidence of the atrial location of receptors influencing urine flow.Circ Res 1956;4:85–92.

    Google Scholar 

  6. Gauer OH, Henry JP. Circulatory basis of fluid volume control.Phys Rev 1963; 43:423–481.

    Google Scholar 

  7. deWardener HE, Mills IH, Clapham WF, et al. Studies on the efferent mechanism of sodium diuresis which follows the administration of intravenous saline in the dog.Clin Sci 1981;21:249–258.

    Google Scholar 

  8. Kisch B. Electron microscopy of the atrium of the heart. I. Guinea pig.Exp Med Surg 1956;114:99–112.

    Google Scholar 

  9. Jamieson JD, Palade GE. Specific gradules in atrial muscle.J Cell Biol 1984;23:151–172.

    Google Scholar 

  10. deBold AJ, Borenstein HB, Veress AT et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.Life Sci 1981;28:89–94.

    Google Scholar 

  11. Chapeau C, Gutkowska J, Schiller PW, et al. Localization of immunoreactive synthetic atrial natriuretic factor (ANF) in the heart of various animal species.J Histochem Cytochem 1985;33:541–550.

    Google Scholar 

  12. deBold AJ. Heart atrial granularity. Effects of changes in water-electrolyte balance.Proc Soc Exptl Biol Med 1979:161:508–511.

    Google Scholar 

  13. Ackermann DM, Edward BS, Wold LE, et al. Atrial natriuretic peptide: Localization in the human heart.J Am Med Assoc 1986;256:1058.

    Google Scholar 

  14. deBold AJ. Atrial natriuretic factor: A hormone produced by the heart.Science 1985;230:767–770.

    Google Scholar 

  15. Burnett J, Kao PC, Hu DC, et al. Atrial natriuretic peptide elevation in congestive heart failure in the human.Science 1986;231:1145–1147.

    Google Scholar 

  16. Hollister AS, Tanaka I, Imada T, et al. Sodium loading and posture modulate human atrial natriuretic factor plasma levels.Hypertension 1986;8:II106-II111.

    Google Scholar 

  17. Kimura T, Abe K, Ota K, et al. Effects of acute water load, hypertonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans.J Clin Endo and Metab 1986;62:1003–1010.

    Google Scholar 

  18. Larose F, Meloche S, du Souich P, et al. Radioimmunoassay of atrial natriuretic factor: Human plasma levels.Biochem Biophys Res Commun 1985;130:553–558.

    Google Scholar 

  19. Shenker Y, Sider RS, Ostafin EA, et al. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema.J Clin Invest 1985;76:1684–1687.

    Google Scholar 

  20. Weidmann P, Hellmueller B, Uehlinger DE, et al. Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man.J Clin Endo Metab 1986;62:1027–1031.

    Google Scholar 

  21. Dietz JR. Release of natriuretic factor from rat heart-lung preparation by atrial distension.Am J Physiol 1984;247:R1093-R1096.

    Google Scholar 

  22. Epstein M, Loutzenhiser R, Friedland E, et al. Stimulation of plasma ANF in cirrhotic humans by immersion-induced central hypervolemia (abstract).J Cardiovasc Pharmacol (in press).

  23. Burnett JC Jr, Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release.Am J Physiol 1984;247:F863-F866.

    Google Scholar 

  24. Maack T, Marion DN, Camargo MJ, et al. Effect of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.Am J Med 1984;77:1069–1075.

    Google Scholar 

  25. Camargo MJF, Kleinert HD, Atlas SA, et al. Ca-dependent hemodynamic and natriuretic effects of atrial extract in isolated rat kidney.Am J Physiol 1984;246:F447-F456

    Google Scholar 

  26. Opgenorth TJ, Burnett JC Jr, Granger JP, et al. Effects of atrial natriuretic peptide on renin secretion in nonfiltering kidney.Am J Physiol 1986;250:F798-F801.

    Google Scholar 

  27. Burnett JC Jr, Opgenorth TJ, Granger JP. The renal actions of atrial natriuretic peptide during control of glomerular filtration.Kidney Int 1986;30:16–19.

    Google Scholar 

  28. Burnett JCJr, Edwards BS, Schwab TR, et al. Renal cardiovascular endocrine actions of atrial natriuretic peptide in humans with congestive heart failure (abstract).Clin Res (in press).

  29. Schwab TR, Edwards BS, Zimmerman RS, et al. Renal interstitial hydrostatic pressure dynamics during atrial natriuetic peptide administration. In: Brenner B, Laragh J, eds.Proc. First World Cong of Biologically Active Atrial Peptides. New York: Raven Press (in press).

  30. Dunn BR, Troy JL, Ichikawa I, et al. Effect of atrial natriuretic peptide (ANP) on hydraulic pressures in the rat renal papilla: Implications for ANP-induced natriuresis.Kidney Int 1986;29:382, (Abstract).

    Google Scholar 

  31. Goetz KL. Atrial receptors, natriuretic peptides, and the kidney. Current understanding.Mayo Clinic Proc 1986;61:600–603.

    Google Scholar 

  32. Goetz K, Wang D, Geer PG, et al. Atrial stretch increases sodium excretion independently of release of atrial peptides.Am J Physiol 1986;250:R946-R950.

    Google Scholar 

  33. Veress AT, Sonnenberg H. Right atrial appendectomy reduces the renal response to acute hypervolemia in the rat.Am J Physiol 1984;247:R610-R613.

    Google Scholar 

  34. Schwab TR, Edwards BS, Heublein DM, et al. The role of atrial natriuretic peptide in volume expansion natriuresis.Am J Physiol 1986;251:R310-R313.

    Google Scholar 

  35. Thurau K, Grüner A, Mason J, et al. Tubular signal for renin activity in the juxtaglomerular apparatus.Kidney Int 1982;22:S12:555–562.

    Google Scholar 

  36. Atarashi K, Mulrow PJ, Franco-Saenz R, et al. Inhibition of aldosterone production by atrial extract.Science 1984;224:992–993.

    Google Scholar 

  37. Campbell WB, Currie MC, Needleman P. Inhibition of aldosterone biosynthesis by atriopeptins in rat adrenal cells.Circ Res 1985;57:113–118.

    Google Scholar 

  38. DeLean A, Racz K, Gutkowska J, et al. Specific receptor-mediated inhibition by synthetic atrial natriuretic factor of hormone-stimulated steroidogenesis in cultured bovine adrenal cells.Endocrinology 1984;115:1636–1638.

    Google Scholar 

  39. Goodfriend TL, Elliott MW, Atlas SA. Actions of synthetic atrial natriretic factor on bovine adrenal glomerulosa.Life Sci 1984;35:1675–1682.

    Google Scholar 

  40. Kudo T, Baird A. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor.Nature 1985;312:756–757.

    Google Scholar 

  41. Chartier L, Schiffrin E, Thibault G, et al. Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II, ACTH, and potassium in-vitro and angiotensin II-induced steroidogenesis in-vivo.Endocrinology 1984;115:2026–2028.

    Google Scholar 

  42. Atarashi K, Mulrow PJ, Franco-Saenz R. Effect of atrial peptides on aldosterone production.J Clin Invest 1985;76:1807–1811.

    Google Scholar 

  43. Zimmerman RS, Edwards BS, Schwab TR, et al. Dissociation between atrial natriuretic peptide and sodium excretion during volume expansion. In: Brenner BM, Laragh J, eds.Proceedings of the 1st World Congress on Biologically Active Atrial Peptides. New York: Raven Press (in press).

  44. August JT, Nelson DH, Thorn GW. Response of normal subjects to large amounts of aldosterone.J Clin Invest 1958;37:1549–1555.

    Google Scholar 

  45. Ballerman BJ, Bloch KA, Seidman JG, et al. Atrial natriuretic peptide (ANP) secretion, biosynthesis, and glomerular receptor activity during mineralocorticoid escape (abstract).Kidney Int 1985;29:329.

    Google Scholar 

  46. Granger JP, Burnett JC Jr, Romero JC, et al. Temporal changes in plasma atrial natriuretic peptide during aldosterone escape.Fed Proc 1986;45:527 (Abstract).

    Google Scholar 

  47. Takeda T, Miyamori I, Ikeda M. Role of atrial natriuretic polypeptide (ANP) for the pathogenesis of escape from mineralocorticoid excess (abstract).J Cardiovasc Pharmacol (in press).

  48. Zimmerman RS, Edwards BS, Schwab TR, et al. Atrial natriuretic peptide during mineralocorticoid escape in the humanJ Clin Endocrinol Metab (In Press).

  49. Klemm SA, Hamlet SM, Gordon RD. Primary aldosteronism, recumbent posture, and salt loading are associated with higher levels of atrial natriuretic peptide (abstract).Program and Abstracts to World Congress of Biologically Active Atrial Peptides, 1986;88A.

  50. Januszewicz P, Gutkowska J, DeLean A, et al. Synthetic atrial natriuretic factor induces release (possibly receptor-mediated) of vasopressin from rat posterior pituitary.Proc Soc Exptl Biol Med 1985; 178:321–325.

    Google Scholar 

  51. Obana K, Naruse M, Inagami T, et al. Atrial natriuretic factor inhibits vasopressin secretion from rat posterior pituitary.Biochem Biophys Res Comm 1985;132:1088–1094.

    Google Scholar 

  52. Manning PT, Schwartz D, Kasube NC, et al. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis.Science 1985;229:395–397.

    Google Scholar 

  53. Heublein DM, Schwab TR, Edwards BS, et al. Human platelet-rich and platelet-poor plasma atrial natriuretic peptide levels during dehydration. In: Brenner BM, Laragh J, eds.Proceedings of the First World Congress on Biologically Active Atrial Peptides. New York: Raven Press, (in press).

  54. Dillingham MA, Anderson RJ. Inhibition of vasopressin action by atrial natriuretic factor.Science 1986;231:1572–1573.

    Google Scholar 

  55. Ladenson PW, Michener M, Langevin H, et al. Plasma and atrial atriopeptin concentrations in hyperthyroid, euthyroid and hypothyroid rats (abstract).Program and Abstracts to Endocrine Society, 1986;235.

  56. Gardner DH, Hane S, Gertz BJ. Expression of the gene for trial natriuretic factor is regulated by thyroid hormone (abstract).Program and Abstracts to Endocrine Society 1986;60.

  57. Zimmerman RS, Gharib H, Zimmerman D, et al. Atrial natriuretic factor in hypothyroidism.J Clin Endocrinol Metab 1987;64:353–355.

    Google Scholar 

  58. Ardaillou N, Nivez MP, Ardaillou R. Stimulation of guanylate cyclase by atrial natriuretic factor in isolated human glomeruli.Fed Eur Biochem Soc 1985;189:8–12.

    Google Scholar 

  59. Cantiello HF, Ausiello DA. Atrial natriuretic factor and cGMP inhibit amiloride-sensitive Na+ transport in the cultured renal epithelial cell line LLC-PK1.Biochem Biophys Res Comm 1986;134:852–860.

    Google Scholar 

  60. Gerzer R, Witzgall H, Tremblay J, et al. Rapid increase and plasma and urinary cyclic GMP after bolus injection of atrial natriuretic factor in man.J Clin Endocrinol Metab 1985;61:1217–1219.

    Google Scholar 

  61. Ichikawa S, Saito T, Okada K, et al. Atrial natriuretic factor increases cyclic GMP and inhibits cyclic AMP in rat renal papillary collecting tubule cells in culture.Biochem Biophys Res Comm 1985;130:1147–1153.

    Google Scholar 

  62. Mittal CK. Atriopeptin II and nitrovasodilator-mediated shifts in guanosine 3′,5′ cyclic monophosphate in rat thoracic aorta: Evidence for involvement of distinct guanylate cyclase pools.Eur J. Pharmacol 1985;115:127–8.

    Google Scholar 

  63. Ohlstein EG, Berkowitz BA. Cyclic guanosine monophosphate mediates vascular relaxation induced by atrial natriuretic factor.Hypertension 1985;7:306–310.

    Google Scholar 

  64. Waldman SA, Rapoport RM, Fiscus RR, et al. Effects of atriopeptin on particulate guanylate cyclase from rat adrenal.Biochim Biophys Acta 1985;845:298–303.

    Google Scholar 

  65. Winquist RJ, Faison EP, Waldman SA, et al. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.Proc Natl Acad Sci 1984;81:7661–7664.

    Google Scholar 

  66. Inui K, Saito H, Matsukawa Y, et al. Specific binding activities and cyclic GMP responses by atrial natriuretic polypeptide in kidney epithelial cell line (LLC-PK1).Biochem Biophys Res Comm 1985;132:253–260.

    Google Scholar 

  67. Huang C, Ives HE, Cogan MC. Intrarenal arterial infusion of dibutyryl cyclic GMP (DBcGMP) can cause glomerular hyperfiltration, in-vivo evidence that cGMP serves as a second messenger for ANF (abstract).J Cardiovasc Pharmacol (in press).

  68. Blaine EH, Seymour AA, Marsh EA, et al. Effects of atrial natriuretic factor on renal function and cyclic GMP production.Fed Proc 1986;45:2122–2127.

    Google Scholar 

  69. Currie MG, Geller DM, Cole BR, et al. Bioactive cardiac substances: Potent vasorelaxant activity in mammalian atria.Science 1983;221:71–73.

    Google Scholar 

  70. Garcia R, Thibault G, Cantin M, et al. Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds.Am J Physiol 1984;247:R34-R39.

    Google Scholar 

  71. Ishihara T, Aisaka K, Hattori K, et al. Vasodilatory and diuretic actions of alpha-human atrial natriuretic polypeptide (alpha-hANP).Life Sci 1985;36:1205–1215.

    Google Scholar 

  72. Breuhaus B, Saneil H, Brandt M, et al. Atriopeptin II lowers cardiac output in conscious sheep.Am J Physiol 1985;249:R776-R780.

    Google Scholar 

  73. Edwards BS, Schwab TR, Zimmerman RS, et al. Cardiovascular, renal and endocrine response to atrial natriuretic peptide in angiotensin II mediated hypertension.Circ Res 1986;59:663–667.

    Google Scholar 

  74. Kleinert HD, Volpe M, Odell G, et al. Cardiovascular effect of atrial natriurtic factor in anesthetized and conscious dogs.Hypertension 1986;8:312–316.

    Google Scholar 

  75. Lappe RW, Smits JFM, Todt JA, et al. Failure of atriopeptin II to cause arterial vasodilation in the conscious rat.Circ Res 1985;56:606–612.

    Google Scholar 

  76. Wangler RD, Breuhaus BA, Otero HO, et al. Coronary vasoconstrictor effects of antriopeptin II.Science 1985;230:598–561.

    Google Scholar 

  77. Burnett JCJr, Rubanyi GM, Edwards BS, et al. Atrial natriuretic peptide effects on cardiac function in vivo and in vitro. In: Brenner B, Laragh J, eds.Proceedings of the First World Congress of Biologically Active Atrial Peptides. New York: Raven Press, (in press).

  78. Mark AL, Thoren P, O'Neill TP, et al. Atriopeptin stimulates cardiac sensory receptors with vagal afferents in rats (abstract).Clin Res 1985;33:596A.

    Google Scholar 

  79. Biollaz J, Nussberger J, Porchet M, et al. Four hour infusion of synthetic atrial natriuretic peptide in normal volunteers.Hypertension 1986;8:II96-II105.

    Google Scholar 

  80. Richards AM, Nicholls MG, Ikram H, et al. Renal, haemodynamic, and hormonal effects of human alpha atrial natriuretic peptide in healthy volunteers.Lancet 1985;1:545–549.

    Google Scholar 

  81. Weidmann P, Hasler L, Gnadinger MP, et al. Blood levels and renal effects of atrial natriuretic peptide in normal man.J Clin Invest 1986;77:734–742.

    Google Scholar 

  82. Chimoskey JE, Spielman WS, Brandt MA, et al. Cardiac atria of bio 14.6 hamsters are deficient in natriuretic factor.Science 1984;223:820–822.

    Google Scholar 

  83. Edwards BS, Ackerman DM, Schwab TR, et al. The relationship between atrial granularity and circulating atrial natriuretic peptide in hamsters with congestive heart failure.Mayo Clinic Proc 1986;61:517–521.

    Google Scholar 

  84. Stopps TP, deBold AJ, Forster C, et al. Experimental heart failure: Atrial natriuretic factor and other neuroendocrine changes during rapid ventricular pacing (abstract).Clin Res 1986;34:347.

    Google Scholar 

  85. Haramati A, Burnett JCJr, Hoffman A, et al. Renal response to atrial natriuretic factor in rats with experimental high-output heart failure (abstract).Circ Res 1986;34:587A.

  86. Bates ER, Shenker Y, Gerkin RJ. The relationship between plasma levels of immunoactive atrial natriuretic hormone and hemodynamic function in man.Circulation 1986;73:1155–1161.

    Google Scholar 

  87. Scrivin TA, Burnett JC Jr. Effects of synthetic atrial natriuretic peptide on renal function and renin release on acute experimental heart failure.Circulation 1985;72:892–897.

    Google Scholar 

  88. Freeman RH, Davis JO, Vari RC. Renal response to atrial natriuretic factor in conscious dogs with caval constriction.Am J Physiol 1985;248:R495-R500.

    Google Scholar 

  89. Arendt RM, Gerbes AL, Ritter D, et al. Plasma-ANF in various disease states (abstract).J Cardiovasc Pharmacol (in press).

  90. Wood P. Polyuria in paroxysmal tachycardia and paroxysmal atrial flutter and fibrillation.Br Heart J 1963;25:273–282.

    Google Scholar 

  91. Gutkowska J, Bourassa M, Roy D, et al. Immunoreactive atrial natriuretic factor (IR-ANF) in human plasma.Biochem Biophys Res Comm 1985;128:1350–1357.

    Google Scholar 

  92. Miller WL, Edwards BS, Zimmerman RS, et al. Dissociation between atrial natriuretic factor and renal sodium excretion (UNaV) in response to tachycardia in the dog (abstract).Kidney Int (in press).

  93. Osborn MJ, Hammill SC, Burnett JC Jr. Enhanced levels of circulating atrial natriuretic peptide during ventricular pacing in humans (abstract).J Am Coll Card 1986;7(2):A192.

    Google Scholar 

  94. Schiffrin EL, Gutkowska J, Kichel O, et al. Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia.New Engl J Med 1985;312:1196.

    Google Scholar 

  95. Tikkanen I, Metsarinne K, Fyhrquist F. Atrial natriuretic peptide in paroxysmal supraventricular tachycardia.Lancet 1985;ii:40–41.

    Google Scholar 

  96. Yamaji T, Ishibashi M, Makaoka H, et al. Possible role for atrial natriuretic peptide in polyuria associated with paroxysmal atrial arrhythmias (abstract).Lancet 1985;1:1211.

    Google Scholar 

  97. Cody RJ, Kubo SJ, Atlas SA, et al. The vasodilator properties of atrial natriuretic factor in man: Assessment with an isolated limb preparation (abstract).J Cardiovasc Pharmacol (in press).

  98. Cody RJ, Kubo SH, Atlas, SA, et al. Atrial natriuretic factor in heart failure: Endogenous activity and response to exogenous administration (abstract).J Cardiovasc Pharmacol (in press).

  99. Linas SL, Schrier RW. Disorders of the renin-angiotensin-aldosterone system. In: Schrier RW, ed.Renal and Electrolyte Disorders. Boston: Little Brown, 1986.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine and Physiology and Biophysics, Mayo Medical School, 55905, Rochester, Minnesota

    Brooks S. Edwards M.D., Robert S. Zimmerman & John C. Burnett Jr.

Authors
  1. Brooks S. Edwards M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert S. Zimmerman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. John C. Burnett Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edwards, B.S., Zimmerman, R.S. & Burnett, J.C. Atrial natriuretic factor: Physiologic actions and implications in congestive heart failure. Cardiovasc Drug Ther 1, 89–100 (1987). https://doi.org/10.1007/BF02125838

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02125838

Key words

Search

Navigation